Akribion Genomics AG (since 6/23)

https://www.akribion-genomics.com

As a brand name of BRAIN Biotech AG, Akribion Genomics focuses on developing groundbreaking CRISPR nucleases into a new class of genetics-based cancer therapies and advanced genome editing tools, powered by the BRAIN Biotech Group BioIncubator. Akribion Genomics’ flexible CRISPR-based gene editing technology platform features distinct technology families (G-dases®) with broad application in Industrial Biotechnology and Agriculture, and offers a groundbreaking technological advantage for therapeutic and diagnostic solutions. Akribion Genomics is committed to using its technology with high ethical standards to improve products, processes and medical treatments. Its goal is to develop new treatment approaches in oncology by employing novel CRISPR technology that allows targeted cell depletion using RNA biomarkers. In addition, access to advanced CRISPR genome editing technology with freedom-to-operate will be made more feasible. Akribion Genomics is a spin-off in founding of BRAIN Biotech AG, a renowned international group of companies providing innovative biobased products and solutions to industry. For additional information, please visit www.akribion-genomics.com and LinkedIn. *

	Start	2023-06-06 reorganised
	Predecessor	Akribion Genomics (genome editing business of BRAIN Biotech AG until 6/23)
	Industry	G-dase® technology platform (formerly BEC CRISPR technology)
	Industry 2	industrial biotechnology
	Person	Linnig, Lukas (BRAIN Biotech 202210– Business Head of Akribion Genomics before CFO of BRAIN AG joined 201704)
	Person 2	Krohn, Michael (BRAIN Biotech 202210– RnD Head of Akribion Genomics before RnD Head of BRAIN Biotech AG)

	Region	Zwingenberg
	Country	Germany
	Street	34-36 Darmstädter Str.
	City	64673 Zwingenberg
		Address record changed: 2023-10-12

Basic data	Employees	n. a.

		* Document for »About Section«: BRAIN Biotech AG. (9/28/23). "Press Release: BRAIN Biotech AG´s Akribion Genomics Team Wins First Prize in the “BioRiver Boost!” Startup Competition". Zwingenberg.

		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Akribion Genomics AG (since 6/23)

[1] BRAIN Biotech AG. (9/28/23). "Press Release: BRAIN Biotech AG´s Akribion Genomics Team Wins First Prize in the “BioRiver Boost!” Startup Competition". Zwingenberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)